36C25725Q0197 LineItems.xlsx
XLSX spreadsheet 462 KB Posted
- Attached to
- Q301--Amendment to Post Technical Q's and Extend Closing Date - NTX Reference Lab Testing Federal contract opportunity
- Solicitation number
- 36C25725Q0197
About this file
This is a line item spreadsheet for VA solicitation 36C25725Q0197 listing 43 medical laboratory testing services required by the VA North Texas Health Care System. The services include specialized tests such as genetic mutation analysis, viral/bacterial cultures, antibody testing, and various diagnostic panels, each with specific CPT codes. The base period runs from 5/15/25 to 5/14/26, with four one-year option periods extending through 5/14/30.
The line items maintain consistent quantities across all periods, with examples including 75 Adalimumab antibody tests annually, 160 Chromogranin A serum tests, 152 Hemochromatosis mutation tests, and 240 JAK2 mutation tests. Each line item includes specific CPT codes for billing and is classified under NAICS code 621511 (Medical Laboratories) with service code Q301. The spreadsheet includes fields for unit pricing but shows no populated price values. A reserved line item is included in each period for additional laboratory tests not yet developed.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| S02-36C25725Q0197-Rev1.pdf | ||
| 36C25725Q0197-Technical Questions.pdf | ||
| 36C25725Q0197 0001.pdf | ||
| 36C25725Q0197 0001_1.docx | DOCX document | |
| QASP NTX Reference Lab.pdf | ||
| S02-36C25725Q0197.pdf | ||
| Wage Determination No. 2015-5227, Rev. 24.pdf | ||
| 36C25725Q0197_1.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Action Line Item Information
| Action Type Name | Primary ID | Secondary ID | Mod Number | Title | Order Discount Type Name | Order Discount Type | Order Discount |
| RFQ | 36C25725Q0197 | New - NTX Reference Lab Testing (Base+4) | Percent | 0 |
KB Version: FY25.02A
Items
| ITEM NUMBER | SLIN | DESCRIPTION | REF CLIN | COMMENT | INCLUDE COMMENTS IN DOCUMENT | CONTRACT PERIOD | POP BEGIN | POP END | QUANTITY | UNIT OF MEASURE | PACKAGING MULTIPLE | RECEIPT TYPE | LINE ITEM IS | UNIT PRICE | ITEM DISCOUNT TYPE NAME | ITEM DISCOUNT | DATE UPDATED | ADDRESS1 | ADDRESS2 | ADDRESS3 | CITY | STATE | ZIP | ZIP4 | COUNTRY | MARK FRO | CONTACT NAME | CONTACT PHONE | CONTACT EMAIL | DDELIVERY DATE | FOB | SPECIAL INSTRUCTIONS | INCLUDE INSTRUCTIONS/COMMENTS IN DOCUMENT | INCLUDE DATA VALUES IN DOCUMENT | PRINCIPAL NAICS CODE | PRODUCT/SERVICE CODE | UNSPSC | SIC CODE | MANUFACTURER PART NUMBER (MPN) | NATIONAL STOCK NUMBER | LOCAL STOCK NUMBER | DM DOC ID | DELIVERY REF. COUNTER | UNIT TEXT/DESCRIPTION | DELIVERY REFERENCE | ITEM MASTER FILE NUMBER | EXPENDABLE/NON-EXPENDABLE | QUANTITY REQUESTED | UNIT OF PURCHASE CODE |
| 0001 | Adalimumab and Antibodies to Adalimumab Quantitation CPT codes 80145 82397 | Adalimumab and Antibodies to Adalimumab Quantitation CPT codes 80145 82397 | No | Base | 5/15/25 | 5/14/26 | 75 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80145,82397 | 0 | 0 | E | 75.00 | EA | |||||||||||||||||||||||
| 0002 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication CPT code 81269 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication CPT code 81269 | No | Base | 5/15/25 | 5/14/26 | 8 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81269 | 0 | 0 | E | 8.00 | EA | |||||||||||||||||||||||
| 0003 | Alpha Subunit, Free, Pituitary Glycoprotein Hormones (PGH) CPT code: 83520 | Alpha Subunit, Free, Pituitary Glycoprotein Hormones (PGH) CPT code: 83520 | No | Base | 5/15/25 | 5/14/26 | 7 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83520 | 0 | 0 | E | 7.00 | EA | |||||||||||||||||||||||
| 0004 | Arbovirus Antibodies, IgG and IgM, CSF CPT codes:86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788 | Arbovirus Antibodies, IgG and IgM, CSF CPT codes:86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788 | No | Base | 5/15/25 | 5/14/26 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 0005 | Aspergillus Galactomannan Antigen by EIA, Bronchoscopy CPT code 87305 | Aspergillus Galactomannan Antigen by EIA, Bronchoscopy CPT code 87305 | No | Base | 5/15/25 | 5/14/26 | 25 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87305 | 0 | 0 | E | 25.00 | EA | |||||||||||||||||||||||
| 0006 | Quantitative Detection of BCR-ABL1, Minor Form (p190) CPT code 81207 | Quantitative Detection of BCR-ABL1, Minor Form (p190) CPT code 81207 | No | Base | 5/15/25 | 5/14/26 | 41 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81207 | 0 | 0 | E | 41.00 | EA | |||||||||||||||||||||||
| 0007 | Beta-2 Transferrin CPT code 86335 | Beta-2 Transferrin CPT code 86335 | No | Base | 5/15/25 | 5/14/26 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86335 | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 0008 | BK Virus by Quantitative NAAT, Plasma CPT code 87799 | BK Virus by Quantitative NAAT, Plasma CPT code 87799 | No | Base | 5/15/25 | 5/14/26 | 22 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87799 | 0 | 0 | E | 22.00 | EA | |||||||||||||||||||||||
| 0009 | Chromogranin A serum CPT code 83616 | Chromogranin A serum CPT code 83616 | No | Base | 5/15/25 | 5/14/26 | 160 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83616 | 0 | 0 | E | 160.00 | EA | |||||||||||||||||||||||
| 0010 | Cytomegalovirus by Qualitative PCR CPT code 87496 | Cytomegalovirus by Qualitative PCR CPT code 87496 | No | Base | 5/15/25 | 5/14/26 | 10 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87496 | 0 | 0 | E | 10.00 | EA | |||||||||||||||||||||||
| 0011 | Autoimmune Encephalopathy/Dementia Panel, Serum CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | Autoimmune Encephalopathy/Dementia Panel, Serum CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | No | Base | 5/15/25 | 5/14/26 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 0012 | Autoimmune Encephalopathy/Dementia Panel, CSF CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | Autoimmune Encephalopathy/Dementia Panel, CSF CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | No | Base | 5/15/25 | 5/14/26 | 13 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 13.00 | EA | |||||||||||||||||||||||
| 0013 | (1,3)-Beta-D-Glucan (Fungitell) CPT code: 87449 | (1,3)-Beta-D-Glucan (Fungitell) CPT code: 87449 | No | Base | 5/15/25 | 5/14/26 | 15 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87449 | 0 | 0 | E | 15.00 | EA | |||||||||||||||||||||||
| 0014 | Helicobacter pylori culture CPT codes 87070; 87176; Identification and susceptibility CPT codes may vary based on method | Helicobacter pylori culture CPT codes 87070; 87176; Identification and susceptibility CPT codes may vary based on method | No | Base | 5/15/25 | 5/14/26 | 12 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 12.00 | EA | |||||||||||||||||||||||
| 0015 | Hemochromatosis (HFE) Mutations CPT 81256 | Hemochromatosis (HFE) Mutations CPT 81256 | No | Base | 5/15/25 | 5/14/26 | 152 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81256 | 0 | 0 | E | 152.00 | EA | |||||||||||||||||||||||
| 0016 | Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT | Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT | No | Base | 5/15/25 | 5/14/26 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87535 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 0017 | HLA-B*57:01 for Abacavir Sensitivity CPT code: 81381 | HLA-B*57:01 for Abacavir Sensitivity CPT code: 81381 | No | Base | 5/15/25 | 5/14/26 | 11 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81381 | 0 | 0 | E | 11.00 | EA | |||||||||||||||||||||||
| 0018 | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | No | Base | 5/15/25 | 5/14/26 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81381 | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 0019 | Inflammatory Bowel Disease Differentiation Panel CPT codes: 86036; 86671 x2 | Inflammatory Bowel Disease Differentiation Panel CPT codes: 86036; 86671 x2 | No | Base | 5/15/25 | 5/14/26 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86036,86671 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 0020 | Infliximab and Antibodies to Infliximab Quantitation CPT codes 80230,82397 | Infliximab and Antibodies to Infliximab Quantitation CPT codes 80230,82397 | No | Base | 5/15/25 | 5/14/26 | 134 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80230,82397 | 0 | 0 | E | 134.00 | EA | |||||||||||||||||||||||
| 0021 | Calculi (Stone) Analysis CPT code 82365 | Calculi (Stone) Analysis CPT code 82365 | No | Base | 5/15/25 | 5/14/26 | 125 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 82365 | 0 | 0 | E | 125.00 | EA | |||||||||||||||||||||||
| 0022 | KIT (D816V) Mutation by ddPCR, Quantitative CPT 81273 | KIT (D816V) Mutation by ddPCR, Quantitative CPT 81273 | No | Base | 5/15/25 | 5/14/26 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81273 | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 0023 | Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing CPT code 81455 | Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing CPT code 81455 | No | Base | 5/15/25 | 5/14/26 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81455 | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 0024 | Muscle-Specific Kinase (MuSK) Antibody, IgG by CBA-IFA with Reflex to Titer, Serum CPT codes:86366 if reflexed, add 86256 | Muscle-Specific Kinase (MuSK) Antibody, IgG by CBA-IFA with Reflex to Titer, Serum CPT codes:86366 if reflexed, add 86256 | No | Base | 5/15/25 | 5/14/26 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86366 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 0025 | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, serum CPT code 84182 | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, serum CPT code 84182 | No | Base | 5/15/25 | 5/14/26 | 40 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 84182 | 0 | 0 | E | 40.00 | EA | |||||||||||||||||||||||
| 0026 | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86362; if reflexed, add 86256 | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86362; if reflexed, add 86256 | No | Base | 5/15/25 | 5/14/26 | 29 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86362 | 0 | 0 | E | 29.00 | EA | |||||||||||||||||||||||
| 0027 | 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG CPT code 83516 | 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG CPT code 83516 | No | Base | 5/15/25 | 5/14/26 | 19 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83516 | 0 | 0 | E | 19.00 | EA | |||||||||||||||||||||||
| 0028 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86052; if reflexed, add 86256 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86052; if reflexed, add 86256 | No | Base | 5/15/25 | 5/14/26 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86052 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 0029 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF CPT code 86052; if reflexed, add 86256 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF CPT code 86052; if reflexed, add 86256 | No | Base | 5/15/25 | 5/14/26 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86052 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 0030 | Aerobic Organism Identification CPT codes 87077 and/or 87153; CPT codes for identification vary based on method. | Aerobic Organism Identification CPT codes 87077 and/or 87153; CPT codes for identification vary based on method. | No | Base | 5/15/25 | 5/14/26 | 27 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 27.00 | EA | |||||||||||||||||||||||
| 0031 | Anaerobic Organism Identification CPT codes 87076 and/or 87153; CPT codes for identification vary based on method. | Anaerobic Organism Identification CPT codes 87076 and/or 87153; CPT codes for identification vary based on method. | No | Base | 5/15/25 | 5/14/26 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 0032 | Phospholipase A2 Receptor (PLA2R) Antibody, IgG with Reflex to Titer CPT codes: 86255; if reflexed, add 86256 | Phospholipase A2 Receptor (PLA2R) Antibody, IgG with Reflex to Titer CPT codes: 86255; if reflexed, add 86256 | No | Base | 5/15/25 | 5/14/26 | 72 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86255 | 0 | 0 | E | 72.00 | EA | |||||||||||||||||||||||
| 0033 | PML-RARA Detection by RT-PCR, Quantitative CPT: 81315 | PML-RARA Detection by RT-PCR, Quantitative CPT: 81315 | No | Base | 5/15/25 | 5/14/26 | 19 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81315 | 0 | 0 | E | 19.00 | EA | |||||||||||||||||||||||
| 0034 | Procollagen Type I Intact N-Terminal Propeptide CPT 83519 | Procollagen Type I Intact N-Terminal Propeptide CPT 83519 | No | Base | 5/15/25 | 5/14/26 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83519 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 0035 | Thiopurine Metabolites in Red Blood Cells CPT code: 80299 | Thiopurine Metabolites in Red Blood Cells CPT code: 80299 | No | Base | 5/15/25 | 5/14/26 | 33 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80299 | 0 | 0 | E | 33.00 | EA | |||||||||||||||||||||||
| 0036 | Ribosomal P Protein Antibody CPT 83516 | Ribosomal P Protein Antibody CPT 83516 | No | Base | 5/15/25 | 5/14/26 | 3 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83516 | 0 | 0 | E | 3.00 | EA | |||||||||||||||||||||||
| 0037 | Aerobic Organism Identification with Reflex to Susceptibility CPT codes vary based on method. | Aerobic Organism Identification with Reflex to Susceptibility CPT codes vary based on method. | No | Base | 5/15/25 | 5/14/26 | 8 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | varies | 0 | 0 | E | 8.00 | EA | |||||||||||||||||||||||
| 0038 | Tickborne Disease Antibodies Panel CPT codes 86753; 86666 x2; 86618; if reflexed, add 86617 x2 | Tickborne Disease Antibodies Panel CPT codes 86753; 86666 x2; 86618; if reflexed, add 86617 x2 | No | Base | 5/15/25 | 5/14/26 | 3 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 3.00 | EA | |||||||||||||||||||||||
| 0039 | Trypanosoma cruzi Antibody, IgG CPT 86753 | Trypanosoma cruzi Antibody, IgG CPT 86753 | No | Base | 5/15/25 | 5/14/26 | 2 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86753 | 0 | 0 | E | 2.00 | EA | |||||||||||||||||||||||
| 0040 | Vedolizumab Quantitation with Antibodies, Serum CPT code 80280, 82397 | Vedolizumab Quantitation with Antibodies, Serum CPT code 80280, 82397 | No | Base | 5/15/25 | 5/14/26 | 50 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80280, 82397 | 0 | 0 | E | 50.00 | EA | |||||||||||||||||||||||
| 0041 | Varicella-Zoster Virus by PCR CPT 87798 | Varicella-Zoster Virus by PCR CPT 87798 | No | Base | 5/15/25 | 5/14/26 | 16 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87798 | 0 | 0 | E | 16.00 | EA | |||||||||||||||||||||||
| 0042 | Viral Culture, Non-Respiratory 87252; if definitive identification required, add 87253 | Viral Culture, Non-Respiratory 87252; if definitive identification required, add 87253 | No | Base | 5/15/25 | 5/14/26 | 11 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87252 | 0 | 0 | E | 11.00 | EA | |||||||||||||||||||||||
| 0043 | JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR and MPL Mutation Detection CPT codes 81270; if reflexed add 81219 and 81338 | JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR and MPL Mutation Detection CPT codes 81270; if reflexed add 81219 and 81338 | No | Base | 5/15/25 | 5/14/26 | 240 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81270 | 0 | 0 | E | 240.00 | EA | |||||||||||||||||||||||
| 0044 | Reserved for additional laboratory tests not yet developed or listed in contract or part of the price schedule NAICS 621511 Service code Q301 | Reserved for additional laboratory tests not yet developed or listed in contract or part of the price schedule NAICS 621511 Service code Q301 | No | Base | 5/15/25 | 5/14/26 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | Varies | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 1001 | Adalimumab and Antibodies to Adalimumab Quantitation CPT codes 80145 82397 | Adalimumab and Antibodies to Adalimumab Quantitation CPT codes 80145 82397 | No | Option 1 | 5/15/26 | 5/14/27 | 75 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80145,82397 | 0 | 0 | E | 75.00 | EA | |||||||||||||||||||||||
| 1002 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication CPT code 81269 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication CPT code 81269 | No | Option 1 | 5/15/26 | 5/14/27 | 8 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81269 | 0 | 0 | E | 8.00 | EA | |||||||||||||||||||||||
| 1003 | Alpha Subunit, Free, Pituitary Glycoprotein Hormones (PGH) CPT code: 83520 | Alpha Subunit, Free, Pituitary Glycoprotein Hormones (PGH) CPT code: 83520 | No | Option 1 | 5/15/26 | 5/14/27 | 7 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83520 | 0 | 0 | E | 7.00 | EA | |||||||||||||||||||||||
| 1004 | Arbovirus Antibodies, IgG and IgM, CSF CPT codes:86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788 | Arbovirus Antibodies, IgG and IgM, CSF CPT codes:86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788 | No | Option 1 | 5/15/26 | 5/14/27 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 1005 | Aspergillus Galactomannan Antigen by EIA, Bronchoscopy CPT code 87305 | Aspergillus Galactomannan Antigen by EIA, Bronchoscopy CPT code 87305 | No | Option 1 | 5/15/26 | 5/14/27 | 25 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87305 | 0 | 0 | E | 25.00 | EA | |||||||||||||||||||||||
| 1006 | Quantitative Detection of BCR-ABL1, Minor Form (p190) CPT code 81207 | Quantitative Detection of BCR-ABL1, Minor Form (p190) CPT code 81207 | No | Option 1 | 5/15/26 | 5/14/27 | 41 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81207 | 0 | 0 | E | 41.00 | EA | |||||||||||||||||||||||
| 1007 | Beta-2 Transferrin CPT code 86335 | Beta-2 Transferrin CPT code 86335 | No | Option 1 | 5/15/26 | 5/14/27 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86335 | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 1008 | BK Virus by Quantitative NAAT, Plasma CPT code 87799 | BK Virus by Quantitative NAAT, Plasma CPT code 87799 | No | Option 1 | 5/15/26 | 5/14/27 | 22 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87799 | 0 | 0 | E | 22.00 | EA | |||||||||||||||||||||||
| 1009 | Chromogranin A serum CPT code 83616 | Chromogranin A serum CPT code 83616 | No | Option 1 | 5/15/26 | 5/14/27 | 160 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83616 | 0 | 0 | E | 160.00 | EA | |||||||||||||||||||||||
| 1010 | Cytomegalovirus by Qualitative PCR CPT code 87496 | Cytomegalovirus by Qualitative PCR CPT code 87496 | No | Option 1 | 5/15/26 | 5/14/27 | 10 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87496 | 0 | 0 | E | 10.00 | EA | |||||||||||||||||||||||
| 1011 | Autoimmune Encephalopathy/Dementia Panel, Serum CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | Autoimmune Encephalopathy/Dementia Panel, Serum CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | No | Option 1 | 5/15/26 | 5/14/27 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 1012 | Autoimmune Encephalopathy/Dementia Panel, CSF CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | Autoimmune Encephalopathy/Dementia Panel, CSF CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | No | Option 1 | 5/15/26 | 5/14/27 | 13 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 13.00 | EA | |||||||||||||||||||||||
| 1013 | (1,3)-Beta-D-Glucan (Fungitell) CPT code: 87449 | (1,3)-Beta-D-Glucan (Fungitell) CPT code: 87449 | No | Option 1 | 5/15/26 | 5/14/27 | 15 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87449 | 0 | 0 | E | 15.00 | EA | |||||||||||||||||||||||
| 1014 | Helicobacter pylori culture CPT codes 87070; 87176; Identification and susceptibility CPT codes may vary based on method | Helicobacter pylori culture CPT codes 87070; 87176; Identification and susceptibility CPT codes may vary based on method | No | Option 1 | 5/15/26 | 5/14/27 | 12 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 12.00 | EA | |||||||||||||||||||||||
| 1015 | Hemochromatosis (HFE) Mutations CPT 81256 | Hemochromatosis (HFE) Mutations CPT 81256 | No | Option 1 | 5/15/26 | 5/14/27 | 152 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81256 | 0 | 0 | E | 152.00 | EA | |||||||||||||||||||||||
| 1016 | Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT | Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT | No | Option 1 | 5/15/26 | 5/14/27 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87535 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 1017 | HLA-B*57:01 for Abacavir Sensitivity CPT code: 81381 | HLA-B*57:01 for Abacavir Sensitivity CPT code: 81381 | No | Option 1 | 5/15/26 | 5/14/27 | 11 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81381 | 0 | 0 | E | 11.00 | EA | |||||||||||||||||||||||
| 1018 | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | No | Option 1 | 5/15/26 | 5/14/27 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81381 | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 1019 | Inflammatory Bowel Disease Differentiation Panel CPT codes: 86036; 86671 x2 | Inflammatory Bowel Disease Differentiation Panel CPT codes: 86036; 86671 x2 | No | Option 1 | 5/15/26 | 5/14/27 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86036,86671 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 1020 | Infliximab and Antibodies to Infliximab Quantitation CPT codes 80230,82397 | Infliximab and Antibodies to Infliximab Quantitation CPT codes 80230,82397 | No | Option 1 | 5/15/26 | 5/14/27 | 134 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80230,82397 | 0 | 0 | E | 134.00 | EA | |||||||||||||||||||||||
| 1021 | Calculi (Stone) Analysis CPT code 82365 | Calculi (Stone) Analysis CPT code 82365 | No | Option 1 | 5/15/26 | 5/14/27 | 125 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 82365 | 0 | 0 | E | 125.00 | EA | |||||||||||||||||||||||
| 1022 | KIT (D816V) Mutation by ddPCR, Quantitative CPT 81273 | KIT (D816V) Mutation by ddPCR, Quantitative CPT 81273 | No | Option 1 | 5/15/26 | 5/14/27 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81273 | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 1023 | Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing CPT code 81455 | Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing CPT code 81455 | No | Option 1 | 5/15/26 | 5/14/27 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81455 | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 1024 | Muscle-Specific Kinase (MuSK) Antibody, IgG by CBA-IFA with Reflex to Titer, Serum CPT codes:86366 if reflexed, add 86256 | Muscle-Specific Kinase (MuSK) Antibody, IgG by CBA-IFA with Reflex to Titer, Serum CPT codes:86366 if reflexed, add 86256 | No | Option 1 | 5/15/26 | 5/14/27 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86366 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 1025 | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, serum CPT code 84182 | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, serum CPT code 84182 | No | Option 1 | 5/15/26 | 5/14/27 | 40 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 84182 | 0 | 0 | E | 40.00 | EA | |||||||||||||||||||||||
| 1026 | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86362; if reflexed, add 86256 | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86362; if reflexed, add 86256 | No | Option 1 | 5/15/26 | 5/14/27 | 29 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86362 | 0 | 0 | E | 29.00 | EA | |||||||||||||||||||||||
| 1027 | 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG CPT code 83516 | 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG CPT code 83516 | No | Option 1 | 5/15/26 | 5/14/27 | 19 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83516 | 0 | 0 | E | 19.00 | EA | |||||||||||||||||||||||
| 1028 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86052; if reflexed, add 86256 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86052; if reflexed, add 86256 | No | Option 1 | 5/15/26 | 5/14/27 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86052 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 1029 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF CPT code 86052; if reflexed, add 86256 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF CPT code 86052; if reflexed, add 86256 | No | Option 1 | 5/15/26 | 5/14/27 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86052 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 1030 | Aerobic Organism Identification CPT codes 87077 and/or 87153; CPT codes for identification vary based on method. | Aerobic Organism Identification CPT codes 87077 and/or 87153; CPT codes for identification vary based on method. | No | Option 1 | 5/15/26 | 5/14/27 | 27 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 27.00 | EA | |||||||||||||||||||||||
| 1031 | Anaerobic Organism Identification CPT codes 87076 and/or 87153; CPT codes for identification vary based on method. | Anaerobic Organism Identification CPT codes 87076 and/or 87153; CPT codes for identification vary based on method. | No | Option 1 | 5/15/26 | 5/14/27 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 1032 | Phospholipase A2 Receptor (PLA2R) Antibody, IgG with Reflex to Titer CPT codes: 86255; if reflexed, add 86256 | Phospholipase A2 Receptor (PLA2R) Antibody, IgG with Reflex to Titer CPT codes: 86255; if reflexed, add 86256 | No | Option 1 | 5/15/26 | 5/14/27 | 72 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86255 | 0 | 0 | E | 72.00 | EA | |||||||||||||||||||||||
| 1033 | PML-RARA Detection by RT-PCR, Quantitative CPT: 81315 | PML-RARA Detection by RT-PCR, Quantitative CPT: 81315 | No | Option 1 | 5/15/26 | 5/14/27 | 19 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81315 | 0 | 0 | E | 19.00 | EA | |||||||||||||||||||||||
| 1034 | Procollagen Type I Intact N-Terminal Propeptide CPT 83519 | Procollagen Type I Intact N-Terminal Propeptide CPT 83519 | No | Option 1 | 5/15/26 | 5/14/27 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83519 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 1035 | Thiopurine Metabolites in Red Blood Cells CPT code: 80299 | Thiopurine Metabolites in Red Blood Cells CPT code: 80299 | No | Option 1 | 5/15/26 | 5/14/27 | 33 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80299 | 0 | 0 | E | 33.00 | EA | |||||||||||||||||||||||
| 1036 | Ribosomal P Protein Antibody CPT 83516 | Ribosomal P Protein Antibody CPT 83516 | No | Option 1 | 5/15/26 | 5/14/27 | 3 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83516 | 0 | 0 | E | 3.00 | EA | |||||||||||||||||||||||
| 1037 | Aerobic Organism Identification with Reflex to Susceptibility CPT codes vary based on method. | Aerobic Organism Identification with Reflex to Susceptibility CPT codes vary based on method. | No | Option 1 | 5/15/26 | 5/14/27 | 8 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | varies | 0 | 0 | E | 8.00 | EA | |||||||||||||||||||||||
| 1038 | Tickborne Disease Antibodies Panel CPT codes 86753; 86666 x2; 86618; if reflexed, add 86617 x2 | Tickborne Disease Antibodies Panel CPT codes 86753; 86666 x2; 86618; if reflexed, add 86617 x2 | No | Option 1 | 5/15/26 | 5/14/27 | 3 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 3.00 | EA | |||||||||||||||||||||||
| 1039 | Trypanosoma cruzi Antibody, IgG CPT 86753 | Trypanosoma cruzi Antibody, IgG CPT 86753 | No | Option 1 | 5/15/26 | 5/14/27 | 2 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86753 | 0 | 0 | E | 2.00 | EA | |||||||||||||||||||||||
| 1040 | Vedolizumab Quantitation with Antibodies, Serum CPT code 80280, 82397 | Vedolizumab Quantitation with Antibodies, Serum CPT code 80280, 82397 | No | Option 1 | 5/15/26 | 5/14/27 | 50 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80280, 82397 | 0 | 0 | E | 50.00 | EA | |||||||||||||||||||||||
| 1041 | Varicella-Zoster Virus by PCR CPT 87798 | Varicella-Zoster Virus by PCR CPT 87798 | No | Option 1 | 5/15/26 | 5/14/27 | 16 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87798 | 0 | 0 | E | 16.00 | EA | |||||||||||||||||||||||
| 1042 | Viral Culture, Non-Respiratory 87252; if definitive identification required, add 87253 | Viral Culture, Non-Respiratory 87252; if definitive identification required, add 87253 | No | Option 1 | 5/15/26 | 5/14/27 | 11 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87252 | 0 | 0 | E | 11.00 | EA | |||||||||||||||||||||||
| 1043 | JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR and MPL Mutation Detection CPT codes 81270; if reflexed add 81219 and 81338 | JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR and MPL Mutation Detection CPT codes 81270; if reflexed add 81219 and 81338 | No | Option 1 | 5/15/26 | 5/14/27 | 240 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81270 | 0 | 0 | E | 240.00 | EA | |||||||||||||||||||||||
| 1044 | Reserved for additional laboratory tests not yet developed or listed in contract or part of the price schedule NAICS 621511 Service code Q301 | Reserved for additional laboratory tests not yet developed or listed in contract or part of the price schedule NAICS 621511 Service code Q301 | No | Option 1 | 5/15/26 | 5/14/27 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | Varies | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 2001 | Adalimumab and Antibodies to Adalimumab Quantitation CPT codes 80145 82397 | Adalimumab and Antibodies to Adalimumab Quantitation CPT codes 80145 82397 | No | Option 2 | 5/15/27 | 5/14/28 | 75 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80145,82397 | 0 | 0 | E | 75.00 | EA | |||||||||||||||||||||||
| 2002 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication CPT code 81269 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication CPT code 81269 | No | Option 2 | 5/15/27 | 5/14/28 | 8 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81269 | 0 | 0 | E | 8.00 | EA | |||||||||||||||||||||||
| 2003 | Alpha Subunit, Free, Pituitary Glycoprotein Hormones (PGH) CPT code: 83520 | Alpha Subunit, Free, Pituitary Glycoprotein Hormones (PGH) CPT code: 83520 | No | Option 2 | 5/15/27 | 5/14/28 | 7 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83520 | 0 | 0 | E | 7.00 | EA | |||||||||||||||||||||||
| 2004 | Arbovirus Antibodies, IgG and IgM, CSF CPT codes:86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788 | Arbovirus Antibodies, IgG and IgM, CSF CPT codes:86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788 | No | Option 2 | 5/15/27 | 5/14/28 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 2005 | Aspergillus Galactomannan Antigen by EIA, Bronchoscopy CPT code 87305 | Aspergillus Galactomannan Antigen by EIA, Bronchoscopy CPT code 87305 | No | Option 2 | 5/15/27 | 5/14/28 | 25 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87305 | 0 | 0 | E | 25.00 | EA | |||||||||||||||||||||||
| 2006 | Quantitative Detection of BCR-ABL1, Minor Form (p190) CPT code 81207 | Quantitative Detection of BCR-ABL1, Minor Form (p190) CPT code 81207 | No | Option 2 | 5/15/27 | 5/14/28 | 41 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81207 | 0 | 0 | E | 41.00 | EA | |||||||||||||||||||||||
| 2007 | Beta-2 Transferrin CPT code 86335 | Beta-2 Transferrin CPT code 86335 | No | Option 2 | 5/15/27 | 5/14/28 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86335 | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 2008 | BK Virus by Quantitative NAAT, Plasma CPT code 87799 | BK Virus by Quantitative NAAT, Plasma CPT code 87799 | No | Option 2 | 5/15/27 | 5/14/28 | 22 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87799 | 0 | 0 | E | 22.00 | EA | |||||||||||||||||||||||
| 2009 | Chromogranin A serum CPT code 83616 | Chromogranin A serum CPT code 83616 | No | Option 2 | 5/15/27 | 5/14/28 | 160 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83616 | 0 | 0 | E | 160.00 | EA | |||||||||||||||||||||||
| 2010 | Cytomegalovirus by Qualitative PCR CPT code 87496 | Cytomegalovirus by Qualitative PCR CPT code 87496 | No | Option 2 | 5/15/27 | 5/14/28 | 10 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87496 | 0 | 0 | E | 10.00 | EA | |||||||||||||||||||||||
| 2011 | Autoimmune Encephalopathy/Dementia Panel, Serum CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | Autoimmune Encephalopathy/Dementia Panel, Serum CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | No | Option 2 | 5/15/27 | 5/14/28 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 2012 | Autoimmune Encephalopathy/Dementia Panel, CSF CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | Autoimmune Encephalopathy/Dementia Panel, CSF CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | No | Option 2 | 5/15/27 | 5/14/28 | 13 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 13.00 | EA | |||||||||||||||||||||||
| 2013 | (1,3)-Beta-D-Glucan (Fungitell) CPT code: 87449 | (1,3)-Beta-D-Glucan (Fungitell) CPT code: 87449 | No | Option 2 | 5/15/27 | 5/14/28 | 15 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87449 | 0 | 0 | E | 15.00 | EA | |||||||||||||||||||||||
| 2014 | Helicobacter pylori culture CPT codes 87070; 87176; Identification and susceptibility CPT codes may vary based on method | Helicobacter pylori culture CPT codes 87070; 87176; Identification and susceptibility CPT codes may vary based on method | No | Option 2 | 5/15/27 | 5/14/28 | 12 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 12.00 | EA | |||||||||||||||||||||||
| 2015 | Hemochromatosis (HFE) Mutations CPT 81256 | Hemochromatosis (HFE) Mutations CPT 81256 | No | Option 2 | 5/15/27 | 5/14/28 | 152 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81256 | 0 | 0 | E | 152.00 | EA | |||||||||||||||||||||||
| 2016 | Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT | Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT | No | Option 2 | 5/15/27 | 5/14/28 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87535 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 2017 | HLA-B*57:01 for Abacavir Sensitivity CPT code: 81381 | HLA-B*57:01 for Abacavir Sensitivity CPT code: 81381 | No | Option 2 | 5/15/27 | 5/14/28 | 11 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81381 | 0 | 0 | E | 11.00 | EA | |||||||||||||||||||||||
| 2018 | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | No | Option 2 | 5/15/27 | 5/14/28 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81381 | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 2019 | Inflammatory Bowel Disease Differentiation Panel CPT codes: 86036; 86671 x2 | Inflammatory Bowel Disease Differentiation Panel CPT codes: 86036; 86671 x2 | No | Option 2 | 5/15/27 | 5/14/28 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86036,86671 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 2020 | Infliximab and Antibodies to Infliximab Quantitation CPT codes 80230,82397 | Infliximab and Antibodies to Infliximab Quantitation CPT codes 80230,82397 | No | Option 2 | 5/15/27 | 5/14/28 | 134 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80230,82397 | 0 | 0 | E | 134.00 | EA | |||||||||||||||||||||||
| 2021 | Calculi (Stone) Analysis CPT code 82365 | Calculi (Stone) Analysis CPT code 82365 | No | Option 2 | 5/15/27 | 5/14/28 | 125 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 82365 | 0 | 0 | E | 125.00 | EA | |||||||||||||||||||||||
| 2022 | KIT (D816V) Mutation by ddPCR, Quantitative CPT 81273 | KIT (D816V) Mutation by ddPCR, Quantitative CPT 81273 | No | Option 2 | 5/15/27 | 5/14/28 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81273 | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 2023 | Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing CPT code 81455 | Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing CPT code 81455 | No | Option 2 | 5/15/27 | 5/14/28 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81455 | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 2024 | Muscle-Specific Kinase (MuSK) Antibody, IgG by CBA-IFA with Reflex to Titer, Serum CPT codes:86366 if reflexed, add 86256 | Muscle-Specific Kinase (MuSK) Antibody, IgG by CBA-IFA with Reflex to Titer, Serum CPT codes:86366 if reflexed, add 86256 | No | Option 2 | 5/15/27 | 5/14/28 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86366 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 2025 | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, serum CPT code 84182 | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, serum CPT code 84182 | No | Option 2 | 5/15/27 | 5/14/28 | 40 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 84182 | 0 | 0 | E | 40.00 | EA | |||||||||||||||||||||||
| 2026 | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86362; if reflexed, add 86256 | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86362; if reflexed, add 86256 | No | Option 2 | 5/15/27 | 5/14/28 | 29 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86362 | 0 | 0 | E | 29.00 | EA | |||||||||||||||||||||||
| 2027 | 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG CPT code 83516 | 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG CPT code 83516 | No | Option 2 | 5/15/27 | 5/14/28 | 19 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83516 | 0 | 0 | E | 19.00 | EA | |||||||||||||||||||||||
| 2028 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86052; if reflexed, add 86256 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86052; if reflexed, add 86256 | No | Option 2 | 5/15/27 | 5/14/28 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86052 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 2029 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF CPT code 86052; if reflexed, add 86256 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF CPT code 86052; if reflexed, add 86256 | No | Option 2 | 5/15/27 | 5/14/28 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86052 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 2030 | Aerobic Organism Identification CPT codes 87077 and/or 87153; CPT codes for identification vary based on method. | Aerobic Organism Identification CPT codes 87077 and/or 87153; CPT codes for identification vary based on method. | No | Option 2 | 5/15/27 | 5/14/28 | 27 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 27.00 | EA | |||||||||||||||||||||||
| 2031 | Anaerobic Organism Identification CPT codes 87076 and/or 87153; CPT codes for identification vary based on method. | Anaerobic Organism Identification CPT codes 87076 and/or 87153; CPT codes for identification vary based on method. | No | Option 2 | 5/15/27 | 5/14/28 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 2032 | Phospholipase A2 Receptor (PLA2R) Antibody, IgG with Reflex to Titer CPT codes: 86255; if reflexed, add 86256 | Phospholipase A2 Receptor (PLA2R) Antibody, IgG with Reflex to Titer CPT codes: 86255; if reflexed, add 86256 | No | Option 2 | 5/15/27 | 5/14/28 | 72 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86255 | 0 | 0 | E | 72.00 | EA | |||||||||||||||||||||||
| 2033 | PML-RARA Detection by RT-PCR, Quantitative CPT: 81315 | PML-RARA Detection by RT-PCR, Quantitative CPT: 81315 | No | Option 2 | 5/15/27 | 5/14/28 | 19 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81315 | 0 | 0 | E | 19.00 | EA | |||||||||||||||||||||||
| 2034 | Procollagen Type I Intact N-Terminal Propeptide CPT 83519 | Procollagen Type I Intact N-Terminal Propeptide CPT 83519 | No | Option 2 | 5/15/27 | 5/14/28 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83519 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 2035 | Thiopurine Metabolites in Red Blood Cells CPT code: 80299 | Thiopurine Metabolites in Red Blood Cells CPT code: 80299 | No | Option 2 | 5/15/27 | 5/14/28 | 33 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80299 | 0 | 0 | E | 33.00 | EA | |||||||||||||||||||||||
| 2036 | Ribosomal P Protein Antibody CPT 83516 | Ribosomal P Protein Antibody CPT 83516 | No | Option 2 | 5/15/27 | 5/14/28 | 3 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83516 | 0 | 0 | E | 3.00 | EA | |||||||||||||||||||||||
| 2037 | Aerobic Organism Identification with Reflex to Susceptibility CPT codes vary based on method. | Aerobic Organism Identification with Reflex to Susceptibility CPT codes vary based on method. | No | Option 2 | 5/15/27 | 5/14/28 | 8 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | varies | 0 | 0 | E | 8.00 | EA | |||||||||||||||||||||||
| 2038 | Tickborne Disease Antibodies Panel CPT codes 86753; 86666 x2; 86618; if reflexed, add 86617 x2 | Tickborne Disease Antibodies Panel CPT codes 86753; 86666 x2; 86618; if reflexed, add 86617 x2 | No | Option 2 | 5/15/27 | 5/14/28 | 3 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 3.00 | EA | |||||||||||||||||||||||
| 2039 | Trypanosoma cruzi Antibody, IgG CPT 86753 | Trypanosoma cruzi Antibody, IgG CPT 86753 | No | Option 2 | 5/15/27 | 5/14/28 | 2 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86753 | 0 | 0 | E | 2.00 | EA | |||||||||||||||||||||||
| 2040 | Vedolizumab Quantitation with Antibodies, Serum CPT code 80280, 82397 | Vedolizumab Quantitation with Antibodies, Serum CPT code 80280, 82397 | No | Option 2 | 5/15/27 | 5/14/28 | 50 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80280, 82397 | 0 | 0 | E | 50.00 | EA | |||||||||||||||||||||||
| 2041 | Varicella-Zoster Virus by PCR CPT 87798 | Varicella-Zoster Virus by PCR CPT 87798 | No | Option 2 | 5/15/27 | 5/14/28 | 16 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87798 | 0 | 0 | E | 16.00 | EA | |||||||||||||||||||||||
| 2042 | Viral Culture, Non-Respiratory 87252; if definitive identification required, add 87253 | Viral Culture, Non-Respiratory 87252; if definitive identification required, add 87253 | No | Option 2 | 5/15/27 | 5/14/28 | 11 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87252 | 0 | 0 | E | 11.00 | EA | |||||||||||||||||||||||
| 2043 | JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR and MPL Mutation Detection CPT codes 81270; if reflexed add 81219 and 81338 | JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR and MPL Mutation Detection CPT codes 81270; if reflexed add 81219 and 81338 | No | Option 2 | 5/15/27 | 5/14/28 | 240 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81270 | 0 | 0 | E | 240.00 | EA | |||||||||||||||||||||||
| 2044 | Reserved for additional laboratory tests not yet developed or listed in contract or part of the price schedule NAICS 621511 Service code Q301 | Reserved for additional laboratory tests not yet developed or listed in contract or part of the price schedule NAICS 621511 Service code Q301 | No | Option 2 | 5/15/27 | 5/14/28 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | Varies | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 3001 | Adalimumab and Antibodies to Adalimumab Quantitation CPT codes 80145 82397 | Adalimumab and Antibodies to Adalimumab Quantitation CPT codes 80145 82397 | No | Option 3 | 5/15/28 | 5/14/29 | 75 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80145,82397 | 0 | 0 | E | 75.00 | EA | |||||||||||||||||||||||
| 3002 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication CPT code 81269 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication CPT code 81269 | No | Option 3 | 5/15/28 | 5/14/29 | 8 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81269 | 0 | 0 | E | 8.00 | EA | |||||||||||||||||||||||
| 3003 | Alpha Subunit, Free, Pituitary Glycoprotein Hormones (PGH) CPT code: 83520 | Alpha Subunit, Free, Pituitary Glycoprotein Hormones (PGH) CPT code: 83520 | No | Option 3 | 5/15/28 | 5/14/29 | 7 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83520 | 0 | 0 | E | 7.00 | EA | |||||||||||||||||||||||
| 3004 | Arbovirus Antibodies, IgG and IgM, CSF CPT codes:86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788 | Arbovirus Antibodies, IgG and IgM, CSF CPT codes:86651 x2; 86652 x2; 86653 x2; 86654 x2; 86789; 86788 | No | Option 3 | 5/15/28 | 5/14/29 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 3005 | Aspergillus Galactomannan Antigen by EIA, Bronchoscopy CPT code 87305 | Aspergillus Galactomannan Antigen by EIA, Bronchoscopy CPT code 87305 | No | Option 3 | 5/15/28 | 5/14/29 | 25 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87305 | 0 | 0 | E | 25.00 | EA | |||||||||||||||||||||||
| 3006 | Quantitative Detection of BCR-ABL1, Minor Form (p190) CPT code 81207 | Quantitative Detection of BCR-ABL1, Minor Form (p190) CPT code 81207 | No | Option 3 | 5/15/28 | 5/14/29 | 41 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81207 | 0 | 0 | E | 41.00 | EA | |||||||||||||||||||||||
| 3007 | Beta-2 Transferrin CPT code 86335 | Beta-2 Transferrin CPT code 86335 | No | Option 3 | 5/15/28 | 5/14/29 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86335 | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 3008 | BK Virus by Quantitative NAAT, Plasma CPT code 87799 | BK Virus by Quantitative NAAT, Plasma CPT code 87799 | No | Option 3 | 5/15/28 | 5/14/29 | 22 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87799 | 0 | 0 | E | 22.00 | EA | |||||||||||||||||||||||
| 3009 | Chromogranin A serum CPT code 83616 | Chromogranin A serum CPT code 83616 | No | Option 3 | 5/15/28 | 5/14/29 | 160 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83616 | 0 | 0 | E | 160.00 | EA | |||||||||||||||||||||||
| 3010 | Cytomegalovirus by Qualitative PCR CPT code 87496 | Cytomegalovirus by Qualitative PCR CPT code 87496 | No | Option 3 | 5/15/28 | 5/14/29 | 10 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87496 | 0 | 0 | E | 10.00 | EA | |||||||||||||||||||||||
| 3011 | Autoimmune Encephalopathy/Dementia Panel, Serum CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | Autoimmune Encephalopathy/Dementia Panel, Serum CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | No | Option 3 | 5/15/28 | 5/14/29 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 3012 | Autoimmune Encephalopathy/Dementia Panel, CSF CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | Autoimmune Encephalopathy/Dementia Panel, CSF CPT codes:86341; 84182 x2; 86255 x10; if reflexed add 84182 x4; 86256 per titer | No | Option 3 | 5/15/28 | 5/14/29 | 13 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 13.00 | EA | |||||||||||||||||||||||
| 3013 | (1,3)-Beta-D-Glucan (Fungitell) CPT code: 87449 | (1,3)-Beta-D-Glucan (Fungitell) CPT code: 87449 | No | Option 3 | 5/15/28 | 5/14/29 | 15 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87449 | 0 | 0 | E | 15.00 | EA | |||||||||||||||||||||||
| 3014 | Helicobacter pylori culture CPT codes 87070; 87176; Identification and susceptibility CPT codes may vary based on method | Helicobacter pylori culture CPT codes 87070; 87176; Identification and susceptibility CPT codes may vary based on method | No | Option 3 | 5/15/28 | 5/14/29 | 12 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 12.00 | EA | |||||||||||||||||||||||
| 3015 | Hemochromatosis (HFE) Mutations CPT 81256 | Hemochromatosis (HFE) Mutations CPT 81256 | No | Option 3 | 5/15/28 | 5/14/29 | 152 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81256 | 0 | 0 | E | 152.00 | EA | |||||||||||||||||||||||
| 3016 | Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT | Human Immunodeficiency Virus 1 (HIV-1) by Qualitative NAAT | No | Option 3 | 5/15/28 | 5/14/29 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 87535 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 3017 | HLA-B*57:01 for Abacavir Sensitivity CPT code: 81381 | HLA-B*57:01 for Abacavir Sensitivity CPT code: 81381 | No | Option 3 | 5/15/28 | 5/14/29 | 11 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81381 | 0 | 0 | E | 11.00 | EA | |||||||||||||||||||||||
| 3018 | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | No | Option 3 | 5/15/28 | 5/14/29 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81381 | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 3019 | Inflammatory Bowel Disease Differentiation Panel CPT codes: 86036; 86671 x2 | Inflammatory Bowel Disease Differentiation Panel CPT codes: 86036; 86671 x2 | No | Option 3 | 5/15/28 | 5/14/29 | 6 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86036,86671 | 0 | 0 | E | 6.00 | EA | |||||||||||||||||||||||
| 3020 | Infliximab and Antibodies to Infliximab Quantitation CPT codes 80230,82397 | Infliximab and Antibodies to Infliximab Quantitation CPT codes 80230,82397 | No | Option 3 | 5/15/28 | 5/14/29 | 134 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 80230,82397 | 0 | 0 | E | 134.00 | EA | |||||||||||||||||||||||
| 3021 | Calculi (Stone) Analysis CPT code 82365 | Calculi (Stone) Analysis CPT code 82365 | No | Option 3 | 5/15/28 | 5/14/29 | 125 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 82365 | 0 | 0 | E | 125.00 | EA | |||||||||||||||||||||||
| 3022 | KIT (D816V) Mutation by ddPCR, Quantitative CPT 81273 | KIT (D816V) Mutation by ddPCR, Quantitative CPT 81273 | No | Option 3 | 5/15/28 | 5/14/29 | 1 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81273 | 0 | 0 | E | 1.00 | EA | |||||||||||||||||||||||
| 3023 | Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing CPT code 81455 | Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing CPT code 81455 | No | Option 3 | 5/15/28 | 5/14/29 | 5 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 81455 | 0 | 0 | E | 5.00 | EA | |||||||||||||||||||||||
| 3024 | Muscle-Specific Kinase (MuSK) Antibody, IgG by CBA-IFA with Reflex to Titer, Serum CPT codes:86366 if reflexed, add 86256 | Muscle-Specific Kinase (MuSK) Antibody, IgG by CBA-IFA with Reflex to Titer, Serum CPT codes:86366 if reflexed, add 86256 | No | Option 3 | 5/15/28 | 5/14/29 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86366 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 3025 | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, serum CPT code 84182 | Myasthenia Gravis/Lambert-Eaton Myasthenic Syndrome Evaluation, serum CPT code 84182 | No | Option 3 | 5/15/28 | 5/14/29 | 40 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 84182 | 0 | 0 | E | 40.00 | EA | |||||||||||||||||||||||
| 3026 | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86362; if reflexed, add 86256 | Myelin Oligodendrocyte Glycoprotein (MOG) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86362; if reflexed, add 86256 | No | Option 3 | 5/15/28 | 5/14/29 | 29 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86362 | 0 | 0 | E | 29.00 | EA | |||||||||||||||||||||||
| 3027 | 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG CPT code 83516 | 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG CPT code 83516 | No | Option 3 | 5/15/28 | 5/14/29 | 19 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 83516 | 0 | 0 | E | 19.00 | EA | |||||||||||||||||||||||
| 3028 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86052; if reflexed, add 86256 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, Serum CPT codes: 86052; if reflexed, add 86256 | No | Option 3 | 5/15/28 | 5/14/29 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86052 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 3029 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF CPT code 86052; if reflexed, add 86256 | Aquaporin-4 (AQP4) Antibody, IgG by CBA-IFA With Reflex to Titer, CSF CPT code 86052; if reflexed, add 86256 | No | Option 3 | 5/15/28 | 5/14/29 | 9 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | 86052 | 0 | 0 | E | 9.00 | EA | |||||||||||||||||||||||
| 3030 | Aerobic Organism Identification CPT codes 87077 and/or 87153; CPT codes for identification vary based on method. | Aerobic Organism Identification CPT codes 87077 and/or 87153; CPT codes for identification vary based on method. | No | Option 3 | 5/15/28 | 5/14/29 | 27 | EA | 0 | Quantity | Priced | Percent | 0 | NONE | No | No | 621511 | Q301 | N/A | N/A | multi | 0 | 0 | E | 27.00 | EA |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .